Smoltek extends evaluation license for its CNF-MIM capacitor technology to increase focus on commercial production aspects

Report this content

This press release is an English version of the previously published Swedish version, which has interpretive precedence. 

'Smoltek Nanotech Holding AB (“Smoltek”) announces that the license agreement, signed with a global manufacturer of electronic components for its technical and commercial evaluation of Smoltek’s capacitor technology, will be further extended to the end of 2021. With satisfactory progress achieved when it comes to validating the performance of the CNF-MIM technology, the project is now moving into a new phase with a stronger focus on commercial production aspects such as reliability, manufacturability and production cost.

The license agreement signed in April 2020 with a world-leading manufacturer of passive electronic components, including capacitors, has previously been extended until the end of August 2021. Even though the project and its timeline has been challenged by COVID-19 related travel restrictions, the collaboration has worked very well, with satisfactory progress achieved by engineers from both parties when it comes to validating the performance of the CNF-MIM technology.

When moving into the new phase of the project, there will be a broader involvement from the licensee so that all relevant commercial production aspects, such as reliability, manufacturability and production cost, can be validated from a business perspective as well as a technical perspective. This phase of the project is expected to be completed around the end of the year. The aim of the project as a whole is to arrive at a point where the licensee has all the data needed to decide on a potential commercial agreement with Smoltek.

“It is exciting to be able to move into the next phase of this project, after having achieved strong progress together with the licensee. We both look forward to now being able to tie every aspect of the project together, and then hopefully conclude that our CNF-MIM technology is ready to be used commercially by the licensee,” says Ola Tiverman, President of the subsidiary Smoltek Semi AB, which is responsible for licensing Smoltek's technology to companies in the semiconductor industry.

For additional information, please contact: 
Marie Landfors, tf CEO of Smoltek Nanotech Holding AB (publ)  
E-mail: marie@smoltek.com 
Phone: +46 760-52 00 53 
Website: www.smoltek.com

Smoltek is a global company that develops process technology and concepts for applications based on carbon nanotechnology to solve advanced materials engineering problems in several industrial sectors. The company protects its unique technology through an extensive and expanding patent portfolio consisting of around 100 applied for patents, of which today 68 have been granted. Smoltek's share is listed on the Spotlight Stock Market in Stockholm, Sweden under the short name SMOL.

Subscribe

Media

Media